Report overview
Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others.
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostics Infectious Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostics Infectious Disease Testing. This report contains market size and forecasts of Molecular Diagnostics Infectious Disease Testing in global, including the following market information:
Global Molecular Diagnostics Infectious Disease Testing Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Molecular Diagnostics Infectious Disease Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Bacterial Infectious Disease Testing Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Molecular Diagnostics Infectious Disease Testing include Abbott Laboratories, BD, bioM?rieux, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens AG, Veridex, Luminex and GenMark Diagnostics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Molecular Diagnostics Infectious Disease Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Diagnostics Infectious Disease Testing Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Molecular Diagnostics Infectious Disease Testing Market Segment Percentages, by Type, 2022 (%)
Bacterial Infectious Disease Testing
Viral Infectious Disease Testing
Parasitic Infectious Disease Testing
Global Molecular Diagnostics Infectious Disease Testing Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Molecular Diagnostics Infectious Disease Testing Market Segment Percentages, by Application, 2022 (%)
Hospital
Laboratory Research
Global Molecular Diagnostics Infectious Disease Testing Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Molecular Diagnostics Infectious Disease Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Molecular Diagnostics Infectious Disease Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Molecular Diagnostics Infectious Disease Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
BD
bioM?rieux
Thermo Fisher Scientific
F. Hoffmann-La Roche
Siemens AG
Veridex
Luminex
GenMark Diagnostics
Qiagen NV
Genomix Biotech
BioTheranostics
GenMark Diagnostics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Molecular Diagnostics Infectious Disease Testing, market overview.
Chapter 2: Global Molecular Diagnostics Infectious Disease Testing market size in revenue.
Chapter 3: Detailed analysis of Molecular Diagnostics Infectious Disease Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Molecular Diagnostics Infectious Disease Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
